Introduction: Corticosteroids therapy is always associated with multiple drug interactions, adverse effects and super infections. Over the years, corticosteroids are apparently being abused by doctors and patients alike. With the increasing number of corticosteroids available for clinicians, there is need to understand the physician’s knowledge, attitude, and practice of corticosteroid use.

Aim and Objectives: To study knowledge, attitude and practice among the practitioners towards the corticosteroid use.

Methods: This prospective, observational, cross-sectional study was carried out over a period of three months among the resident doctors at a tertiary care hospital. Resident doctors from the clinical departments who commonly prescribe corticosteroids in the hospital were included in the study.

Results: Total 70 residents completed the questionnaire. While prescribing the corticosteroids, 88.57% resident doctors gave instruction to their patients to avoid possible adverse effects and drug interactions. Though 94.28% doctors were aware about the different potencies of corticosteroids, only 34.28% were able to arrange them in descending order of their potency. 52.85% doctors were practicing alternate day therapy but only 38.57% were able to justify the alternate day therapy. 31.42% doctors use internet as a source of information while 37.14% refer books while 20% consult senior professional.

Discussion and Conclusion: Corticosteroid is a double- edged weapon. While getting maximum benefits and minimum adverse effects, doctors should be aware of their adverse effects, precautions, duration of treatment. Resident doctors are the first contact physician. Very few resident doctors have detail knowledge about the different potencies, adverse effects, measures to avoid these adverse effects. And there is a need to educate doctors about rational prescribing of corticosteroids.

Keywords: Drug interactions, adverse effects, potency, rational prescribing, corticosteroids.

1. Nieman, Lynnette K, Pharmacologic use of glucocorticoids. In: Up To Date, Basow, DS, Eds. UpToDate, Waltham, MA, 2011.
2. Smith L. Corticosteroids in Solid Organ Transplantation: Update and Review of the Literature. J Pharm Pract. 2003; 16: 380-387
3. Saag KG, Furst DE, Barnes PJ. Major side effects of inhaled glucocorticoids. In: Basow, DS (Ed), UpToDate, Waltham, MA, 2011.
4. Murr AH, Smith TL, Hwang PH, Bhattacharyya N, Lanier BJ, Stambaugh BS, James W, Mugglin, AS. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. International Forum of Allergy & Rhinology. 2012; 1:23-32.
5. Quetta, Balochistan. Irrational use of steroids: a warning for the health care system. Irrational use of steroids: a warning for the health care system. Value in Health 2012:15: A602–A681.
6. Welsh EJ, Cates CJ, Poole P. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. The Cochrane Library 2013; 5: 1-26.
7. Bruno JJ. Dee BM, Anderegg BA, Hernandez M, Pravinkumar SE. US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock. Journal of Critical Care 2012; 27: 351–361.
8. Hannen RF. Michael AE, Jaulim A, Bhogal R, Burrin JM, Philpott MP. Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochemical and Biophysical Research Communications 2011; 404:62–67.
9. Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, Chang HH, Lee JM, and Kim NS. Causes and Treatment Outcomes of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients. Korean J Intern Med 2012; 27:203-210.
10. Gorter SL Bijlsma JW, Cutolo M, Gomez-Reino J, Kouloumas M, and Smolen JS, Landewé R. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommend-dations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010; 69: 1010-4.
11. Minneci P. C. Deans J, Eichacker PQ. Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect 2009; 15: 308–318.
12. Patel GP, And Robert A. Balk Systemic Steroids in Severe Sepsis and Septic Shock. Is J Respir Crit Care Med 2012; 185: 133–139.
13. Rathi S K, D’Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian Journal of Dermatology. 2012 (57)4251-259.
14. Nash JJ, Nash AG, Leach ME, Poetker DM. Medical Malpractice and Corticosteroid Use. Otorhinolaryngology 2010; 1:26-29.
15. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why Don't Physicians Follow Clinical Practice Guidelines? JAMA1999; 282: 1458-1465.
16. Massingham K, Fox S. Asthma Therapy in Pediatric Patients: A Systematic Review of Treatment with Montelukast versus Inhaled Corticosteroids. Journal of Pediatric Health Care 2013; 28:51-62.
17. Frew JW, Dédée MF. Corticosteroid Use in Autoimmune Blistering Diseases. Dermatol Clin 2011; 29: 535–544.
18. Sayah A, Joseph C. Rheumatoid arthritis: A review of the cutaneous manifestations. J Am Acadn Dermatol 2004; 53: 193-209.
19. Shah M, Chaudhari S, Mclaughlin TP. ,Shayan KH, Ferguson K, Singh HK et al. Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients with Systemic Lupus Erythematosus. Clinical Therapeutics 2013; 35: 486-497.
20. Drozdowicz LB, Bostwick MJ. Psychiatric Adverse Effects of Pediatric Corticosteroid Use. Mayo Clin Proc 2014; 89:817-834
21. Mercadante S, Villari P, Intravaia G. Withdrawal acute psychosis after corticosteroid discontinuation. J Pain Symptom Manage 2007; 34: 118-119.
22. Chaudhari H E, Panchmiya H R, Goyal S N, Patil C R. Physicians perception towards corticosteroid as therapeutic agent: A survey. Journal of Pharmaceutical Research and Clinical Practice. Jan-Mar 2015;5(1):1-12
23. Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. International Journal of Dermatology 2010; 49: 239.
24. Weldon D. The effects of corticosteroids on bone growth and bone density. Ann Allergy Asthm Immunol 2009; 103:3–11.
25. Spyridon F, Joseph K, Manuel DA, Maria P, Armand W, Yaw AA. Perseverant, non-indicated treatment of obese patients for obstructive lung disease. BMC Pulmonary Medicine 2013; 10: 13-68.

Shagupta A Naikwadi

Address- Dept. of Pharmacology, Govt. medical college Miraj, Maharashtra. India 416410

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Phone No.- 9766871372